2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Immunologic Factors: new trials by email Literature Review of Immunologic Factors trials Research Report on Immunologic Factors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study Ad26.ZEBOV, MVA-BN-Filo - Virus Diseases, Hemorrhagic Fever, Ebola | Phase 2 | Completed | London School of Hygiene and Tropical Medicine | 133 | 2022-09-19 | 2025-05-11 |
| Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. Subunit recombinant vaccine for the prevention of coronavirus infection, Placebo - COVID-19, Immunologic Factors | Phase 1 / Phase 2 | Completed | St. Petersburg Research Institute of Vaccines and Sera | 155 | 2021-07-19 | 2023-08-30 |
COVID-19 (1) · Coronavirus Infections (1) · Filoviridae Infections (1) · Hemorrhagic Fever, Ebola (1) · Hemorrhagic Fevers, Viral (1) · Infections (1) · Mononegavirales Infections (1) · RNA Virus Infections (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Coronaviridae Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Virus Diseases (1)
London School of Hygiene and Tropical Medicine (1) · St. Petersburg Research Institute of Vaccines and Sera (1)
Russia (1) · Sierra Leone (1)